Association of Glucagon-Like Peptide-1 Receptor Agonist Use With Risk of Gallbladder and Biliary Diseases A Systematic Review and Meta-analysis of Randomized Clinical Trials

He, LY; Wang, JL; Ping, F; Yang, N; Huang, JY; Li, YX; Xu, LL; Li, W; Zhang, HB

Zhang, HB (通讯作者),Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Endocrinol, Key Lab Endocrinol,Natl Hlth Commiss, 1 Shuaifuyuan, Beijing 100730, Peoples R China.

JAMA INTERNAL MEDICINE, 2022; 182 (5): 513

Abstract

IMPORTANCE Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have been widely recommended for glucose control and cardiovascular risk reduction in......

Full Text Link